SEC Form 4 · accession 0001019687-16-007285
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Schutz
Officer — Chief Executive Officer · Director
Period of report
Aug 15, 2016
Accepted (ET)
Aug 16, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 15, 2016 | P | 1,328 | $3.6639 | A | 6,505 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Schutz purchased these shares on the open market.